Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling stat'

Search results for: 'research area jak stat signaling stat'

Items 31-40 of 622

Page
per page
  1. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1/PKA/CDK2 inhibitor,potent and selective
      insoluble in EtOH; ≥23.8 mg/mL
  2. CCT128930 HCl
    A8617 CCT128930 HCl
    Target: Akt
    Summary: AKT inhibitor
      insoluble in H2O; ≥17.1 mg/mL
  3. Palomid 529
    A8618 Palomid 529
    Summary: PI3K/Akt/mTOR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
  4. TIC10
    A8619 TIC10
    Summary: Potent Akt/ERK inhibitor
  5. Rapamycin (Sirolimus)
    A8167 Rapamycin (Sirolimus)
     15 Citation
    Target: mTOR
    Summary: Original antifungal antibiotic
      ≥45.7 mg/mL
  6. Everolimus (RAD001)
    A8169 Everolimus (RAD001)
     8 Citation
    Target: mTOR
    Summary: MTOR inhibitor
      ≥47.91 mg/mL
  7. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     2 Citation
    Target: PI3K
    Summary: PI3K inhibitor
  8. GDC-0068 (RG7440)
    A3006 GDC-0068 (RG7440)
    Target: Akt
    Summary: Pan-AKT inhibitor,highly selective
      ≥22.9 mg/mL
  9. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  10. BKM120
    A3015 BKM120
     1 Citation
    Target: PI3K
    Summary: Inhibitor of pan-Class I PI3K
      ≥20.52 mg/mL

Items 31-40 of 622

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways214item
  2. Protein12item
  3. Kits1 item
  4. Screening Library33item
  5. Modified Nucleotides1 item
  6. Peptides1 item
  7. Molecular Biology3item
  8. Cell Biology12item
  9. Peptides & Proteins58item
  10. Protein & Immunology1 item
  11. Lab Reagents1 item
  12. Antibody63item
  13. Biochemical Reagent218item
Specificity
  1. Selective73item
Reversibility
  1. Reversible6item
  2. Irreversible2item
Target
  1. Cyclin-Dependent Kinases1 item
  2. Cathepsins1 item
  3. Histone Deacetylases (HDACs)12item
  4. Akt9item
  5. PI3K11item
  6. Raf2item
  7. mTOR8item
  8. MMP1 item
  9. Myosin II ATPases1 item
  10. GSK-33item
  11. VEGFR1 item
  12. p381 item
  13. PORCN1 item
  14. Smoothened1 item
  15. Trk Receptors1 item
  16. Aminopeptidases3item
  17. STAT5item
  18. Microtubules/Tubulins1 item
  19. EGFR1 item
  20. RIP kinases1 item
  21. BMP and Other Activin Receptors2item
  22. JAK4item
  23. DNA-PK1 item
  24. Gutathione S-transferase2item
  25. TNKS1 item
  26. Cytochrome P450 (CYP450)1 item
  27. Renin1 item
  28. HIV proteases1 item
  29. Pepsins1 item
  30. Ferroptosis1 item
  31. Toll-like receptors (TLRs)1 item
  32. ERK1 item
  33. HMG-CoA Reductases6item
  34. PKC2item
  35. PKG1 item
  36. PKA3item
  37. RSK1 item
  38. G-quadruplexes1 item
  39. NO Donors / Precursors1 item
  40. IL Receptors1 item
  41. ATGL1 item
  42. DPP-41 item
  43. p70 rsk1 item
  44. Tryptophan hydroxylases (TPH)1 item
  45. Trypsin-like protease1 item
  46. ERAD1 item
  47. Antifungal1 item
  48. Smoothened receptor1 item
  49. Elastases1 item
  50. Antibiotic1 item
  51. HMGCR1 item
  52. Prk1 item
  53. HIF-PH1 item
  54. Adenosine Deaminases1 item
  55. FKBP1 item
  56. NE1 item
Reported Experiments
  1. Animal Experiments91item
  2. Cell Experiments73item
Related Disease
  1. Acute Lung Injury1 item
  2. Acute Myelogenous Leukemia2item
  3. Acute Myeloid Leukemia1 item
  4. Bladder Cancer1 item
  5. Bladder Carcinoma1 item
  6. Breast Cancer17item
  7. Cancer56item
  8. Cervical Cancer1 item
  9. Chronic Lymphocytic Leukemia1 item
  10. Colon Cancer7item
  11. Colon Carcinoma1 item
  12. Colorectal Cancer4item
  13. Dyslipidemia1 item
  14. Glioblastoma4item
  15. Glioma5item
  16. Hepatic Cancer1 item
  17. Hepatocellular Carcinoma1 item
  18. HIV Infections1 item
  19. Hypercholesterolemia2item
  20. Leukemia3item
  21. Liver Cancer1 item
  22. Lung Cancer9item
  23. Lymphoma1 item
  24. Melanoma3item
  25. Multiple Myeloma4item
  26. Myeloma1 item
  27. Neuroblastoma2item
  28. Neuronal Protection1 item
  29. Non-small Cell Lung Cancer1 item
  30. Ovarian Cancer6item
  31. Pancreatic Cancer5item
  32. Prostate Cancer9item
  33. Psoriasis1 item
  34. Pulmonary Fibrosis1 item
  35. Renal Cell Carcinoma1 item
  36. Rheumatoid Arthritis3item
  37. Thyroid Cancer1 item
  38. Type 2 Diabetes1 item